Top Markets
#1 Fake World Assets Fake World Assets +10.69%
#2 B3 (Base) B3 (Base) +10.34%
#3 Janction Janction +9.46%
#4 Verus Coin Verus Coin +7.95%
#5 TENDIES TENDIES +6.38%
#6 GoPlus Security GoPlus Security +4.67%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.03%
#8 Provenance Blockchain Provenance Blockchain +3.76%
#9 Everything Everything +3.72%
#10 OVERTAKE OVERTAKE +3.30%
Coin of the day
Fake World Assets Fake World Assets
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Classement en actions #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Prix de l'action
$0.617
Dernière synchronisation: 2024-10-14
Capitalisation boursière
$6.13M
Changement (1 jour)
0.49%
Changement (1 an)
0.00%
Pays
US
Échange Kineta, Inc. (KA)

Catégorie

Healthcare
EPS pour Kineta, Inc. (KA)
EPS au March 2025 TTM : $-0.66
Selon les derniers rapports financiers et le cours de l'action de Kineta, Inc., l’EPS actuel de la société (TTM) est de $-0.66. À la fin de 2023, la société avait un EPS de $-1.28 une diminution par rapport à celui de 2022, qui était de $-12.80.
Historique de l'EPS de Kineta, Inc. de 2015 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,724.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -4,303.03%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -2,175.77%
BE